Routine versus selective cardiac magnetic resonance in non-ischemic heart failure – OUTSMART-HF: study protocol for a randomized controlled trial (IMAGE-HF (heart failure) project 1-B)
Authors:
- Ian PatersonIPIan Paterson
- George A WellsGWGeorge A Wells
- Justin A EzekowitzJEJustin A Ezekowitz
- James A WhiteJWJames A White
- Matthias G FriedrichMFMatthias G Friedrich
- Lisa M MielniczukLMLisa M Mielniczuk
- Eileen O’mearaEOEileen O’meara
- Benjamin ChowBCBenjamin Chow
- Ran KleinRKRan Klein
- Carole DennieCDCarole Dennie
- Alexander DickADAlexander Dick
Open Access
- 1 January 2013
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 14 (1) , 332
Abstract
Imaging has become a routine part of heart failure (HF) investigation. Echocardiography is a first-line test in HF given its availability and it provides valuable diagnostic and prognostic information. Cardiac magnetic resonance (CMR) is an emerging clinical tool in the management of patients with non-ischemic heart failure. Current ACC/AHA/CCS/ESC guidelines advocate its role in the detection of a variety of cardiomyopathies but there is a paucity of high quality evidence to support these recommendations. The primary objective of this study is to compare the diagnostic yield of routine cardiac magnetic resonance versus standard care (that is, echocardiography with only selective use of CMR) in patients with non-ischemic heart failure. The primary hypothesisis that the routine use of CMR will lead to a more specific diagnostic characterization of the underlying etiology of non-ischemic heart failure. This will lead to a reduction in the non-specific diagnoses of idiopathic dilated cardiomyopathy and HF with preserved ejection fraction. Tertiary care sites in Canada and Finland, with dedicated HF and CMR programs, will randomize consecutive patients with new or deteriorating HF to routine CMR or selective CMR. All patients will undergo a standard clinical echocardiogram and the interpreter will assign the most likely HF etiology. Those undergoing CMR will also have a standard examination and will be assigned a HF etiology based upon the findings. The treating physician’s impression about non-ischemic HF etiology will be collected following all baseline testing (including echo ± CMR). Patients will be followed annually for 4 years to ascertain clinical outcomes, quality of life and cost. The expected outcome is that the routine CMR arm will have a significantly higher rate of infiltrative, inflammatory, hypertrophic, ischemic and ‘other’ cardiomyopathy than the selective CMR group. This study will be the first multicenter randomized, controlled trial evaluating the role of CMR in non-ischemic HF. Non-ischemic HF patients will be randomized to routine CMR in order to determine whether there are any gains over management strategies employing selective CMR utilization. The insight gained from this study should improve appropriate CMR use in HF. NCT01281384 .Keywords
This publication has 42 references indexed in Scilit:
- Canadian Society for Cardiovascular Magnetic Resonance (CanSCMR) Recommendations for Cardiovascular Magnetic Resonance Image Analysis and ReportingCanadian Journal of Cardiology, 2013
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCEuropean Heart Journal, 2012
- Role of Cardiovascular Magnetic Resonance as a Gatekeeper to Invasive Coronary Angiography in Patients Presenting With Heart Failure of Unknown EtiologyCirculation, 2011
- HFSA 2010 Comprehensive Heart Failure Practice GuidelineJournal of Cardiac Failure, 2010
- Cardiovascular Magnetic Resonance in Myocarditis: A JACC White PaperJACC, 2009
- Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinationsJournal of Cardiovascular Magnetic Resonance, 2009
- Assessment of Left Ventricular Systolic Function Using Echocardiography in Patients With Preserved Ejection Fraction and Elevated Diastolic PressuresThe American Journal of Cardiology, 2008
- Effects of Digoxin on Morbidity and Mortality in Diastolic Heart FailureCirculation, 2006
- Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathyJournal of Magnetic Resonance Imaging, 2001
- Underlying Causes and Long-Term Survival in Patients with Initially Unexplained CardiomyopathyNew England Journal of Medicine, 2000